Immunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience

被引：0
|
作者：
Luciani, A. [1 ]
Toschi, L. [2 ]
Fava, S. [3 ]
Cortinovis, D. [4 ]
Filipazzi, V. [5 ]
Tuzi, A. [6 ]
Marra, A. [1 ]
Rossi, S. [2 ]
Rossi, A. [7 ]
Blasi, M. [1 ]
Violati, M. [1 ]
Sala, L. [4 ]
Agustoni, F. [4 ]
Bidoli, P. [4 ]
Zonato, S. [1 ]
Ferrari, D. [1 ]
机构：
[1] Azienda Osped S Paolo, Med Oncol, Milan, Italy
[2] Ist Clin Humanitas, Med Oncol, Rozzano, Italy
[3] Osped Civile Legnano, Med Oncol, Legnano, Italy
[4] Azienda Osped S Gerardo, UO Oncol Med, Med Oncol, Monza, Italy
[5] Osped L Sacco, Med Oncol, Milan, Italy
[6] Osped Circolo Fdn Macchi, Med Oncol, Varese, Italy
[7] IRCCS Casa Sollievo Sofferenza, Med Oncol, San Giovanni Rotondo, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1472P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Exclusions to use of bevacizumab in elderly veterans with advanced non-small cell lung cancer (NSCLC)
    Merza, T.
    Howard, L. M.
    Junagadhwalla, M.
    Gajra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] TREATMENT OF ELDERLY NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS - A PROGNOSTIC INDEX
    Clement, D.
    Marinca, M.
    Miron, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 209 - 209
  • [43] Factors affecting survival in elderly patients with non-small cell lung cancer (NSCLC)
    Athar, U.
    Gandhi, M.
    Lappin, S.
    Newman, N.
    Rajan, A.
    Gajra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [45] Management of Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Single-Center Experience
    Frueh, M.
    Besrour, H.
    Gillessen, S.
    Joerger, M.
    Hitz, F.
    Savidan, A.
    Cerny, T.
    Ess, S.
    CHEMOTHERAPY, 2013, 59 (01) : 42 - 50
  • [46] Vinorelbine and carboplatin in elderly patients with metastatic non-small cell lung cancer (NSCLC): A multicenter phase II study
    Deppermann, Karl-Matthias
    Ukena, Dieter
    von Pawel, Joachim
    Koschel, Gabriele
    Reck, Martin
    Serke, Monika
    Huber, Rudolf-Maria
    Eberhardt, Wilfried
    Niederle, Norbert
    ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [47] Prognostic Factor in Elderly Patients with Advanced Non-small Cell Lung Cancer Accepting Single Agent Immunotherapy
    Yao, Yuanshan
    Gao, Wen
    INDIAN JOURNAL OF SURGERY, 2024, 86 (05) : 1080 - 1081
  • [48] Immunotherapy for advanced non-small cell lung cancer (NSCLC): Experience at Louis Stokes Cleveland VA Medical Center (LSCVAMC).
    Sinclair, Paige
    Nock, Charles John
    Burant, Chris
    Wenzell, Candice
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
    Ramdani, H. O.
    Shatz, S.
    Falk, M.
    Heukamp, L. C.
    Tiemann, M.
    Wesseler, C.
    Schuuring, E.
    Groen, H. J.
    Griesinger, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 153 - 153
  • [50] Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Henon, C.
    Mezquita, L.
    Auclin, E.
    Ammari, S.
    Caramella, C.
    Le Pechoux, C.
    Botticella, A.
    Planchard, D.
    Gazzah, A.
    Ferrara, R.
    Lahmar, J.
    Martinez-Bernal, G.
    Adam, J.
    Soria, J.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2417 - S2417
12345